Latest News for: linnaeus

Edit

Linnaeus Therapeutics Announces Publication of Seminal Paper on LNS8801 in Cancer Research Communications

PR Newswire 20 Mar 2025
HADDONFIELD, N.J., March 20, 2025 /PRNewswire/ -- Linnaeus Therapeutics, Inc ... Linnaeus researchers and collaborators discovered that LNS8801 is the active component of the widely studied GPER agonist, G-1 ... About Linnaeus. Linnaeus Therapeutics, Inc.
  • 1
×